Elonox and Elonox HP (enoxaparin sodium)

pCPA File Number: 21904
Negotiation Status:
Concluded with an LOI
Indication(s):
Thrombosis and cardiovascular conditions (prevention or treatment)
Sponsor/Manufacturer:
Fresenius Kabi Canada Ltd.
CDA-AMC Project Number:
Not Applicable
pCPA Engagement Letter Issued:
Negotiation Process Concluded: